Study adds context to flea- and tick-related disease risk in cats: full analysis
A new Veterinary Sciences study is sharpening the conversation around flea- and tick-related diseases in cats by examining how qPCR and ELISA testing can help detect Cytauxzoon felis in domestic cats from the south-central United States, a region where the pathogen remains especially relevant. The work lands in a clinical landscape where cytauxzoonosis is still one of the most feared feline tick-borne diseases: CAPC says mortality is often high even with treatment, and no vaccine is available. (capcvet.org)
That background matters because feline vector-borne disease has become harder to frame as a simple outdoor-only or acute-only problem. Earlier research has shown that some cats survive natural C. felis infection and may become chronic carriers, while CAPC and international guidance both note that surviving cats can remain persistently infected. At the same time, AAHA/AAFP parasite-control guidance says routine, regular use of broad-spectrum parasite prevention is likely beneficial for most pet cats, regardless of lifestyle, and specifically notes that tick prevention is becoming more important as tick populations increase and expand geographically. (academic.oup.com)
Within that context, the new study’s focus on qPCR versus ELISA is clinically useful. Molecular testing remains the clearest way to identify active parasitemia, but serologic tools may help identify prior exposure that qPCR alone could miss in some cats. That distinction is important in endemic areas, where asymptomatic cats may present for wellness care, blood donor screening, or unrelated illness. Related Oklahoma State research has already explored IgM ELISA approaches for acute cytauxzoonosis and described newer diagnostic development aimed at earlier detection, suggesting a broader push toward tools that could be more practical in real-world feline practice. (mdpi.com)
The disease stakes remain high. CAPC advises clinicians to consider cytauxzoonosis in cats presenting with high fever, lethargy, icterus, dyspnea or tachypnea, lymphadenopathy, and anemia. It identifies the lone star tick as the predominant vector, while also noting historical evidence for transmission by the American dog tick. Current CAPC treatment guidance centers on intravenous fluids, blood transfusions when needed, and atovaquone plus azithromycin with aggressive supportive care. (capcvet.org)
Broader flea- and tick-related disease messaging also supports a more comprehensive prevention story for cats. PetMD’s clinical explainer highlights six tick-borne diseases veterinarians may encounter or discuss with pet parents, including Lyme disease, anaplasmosis, tularemia, and cytauxzoonosis, and notes there is no approved vaccine for tick-borne disease prevention in cats. On the flea side, CAPC says Ctenocephalides felis transmits several zoonotic agents, and CDC states cats usually acquire Bartonella henselae through flea bites, with infected cats then serving as a source of cat scratch disease in people. (petmd.com)
Industry and client-education channels are echoing that risk framing. Fear Free Happy Homes hosts a downloadable “Flea and Tick-Related Diseases in Cats” handout sponsored by Elanco, a sign that parasite prevention messaging is still being actively pushed into the pet parent education space. That kind of handout won’t change standards of care on its own, but it does reflect a continued commercial and educational emphasis on normalizing year-round ectoparasite prevention for cats, including cats that spend most of their time indoors. (fearfreehappyhomes.com)
Why it matters: For veterinary professionals, the bigger takeaway is that feline flea- and tick-related disease management is moving toward a combined prevention-plus-detection model. Prevention remains foundational, but better recognition of asymptomatic exposure, chronic carriage, regional endemicity, and zoonotic crossover risk may change how practices talk about screening, blood donor selection, differential diagnoses, and client compliance. In practical terms, this supports year-round parasite prevention recommendations, sharper triage for febrile or icteric cats in endemic regions, and clearer communication that indoor status does not equal zero risk. (capcvet.org)
What to watch: The next development to watch is whether newer ELISA-based or other patient-side diagnostics for cytauxzoonosis move closer to clinical deployment, and whether expanding tick ranges push more practices outside traditional endemic zones to update feline parasite protocols and client messaging. (mdpi.com)